Becton Dickinson: Leadership Style & Organic Growth
Former Senior Executive at Becton Dickinson
inpractise.com/articles/becton-dickinson-leadership-style-and-organic-growth-investments
Former Senior Executive at Becton Dickinson
Interview Transcript
This is a snippet of the transcript, sign up to read more.
But if you're saying the potential risk of pushing the company too hard would be underinvesting in organic development, which I wanted to ask about later as well, then it's not only about guiding and expecting numbers but also about capital allocation towards acquisitions.
Yes, definitely. He's been pushing the company hard, and when you look at the growth of R&D, it has been modest in the last few years. In the years 2022, 2023, and 2024, you could argue that to make up for inflation, he controlled the R&D spending very tightly. The question I have is, as the company's portfolio moves into higher growth spaces and more Class III devices, part of that includes Bard, the peripheral intervention, and the Edwards APM business. These businesses typically require higher R&D spending than the company's average.
This is a snippet of the transcript, sign up to read more.
But if you're saying the potential risk of pushing the company too hard would be underinvesting in organic development, which I wanted to ask about later as well, then it's not only about guiding and expecting numbers but also about capital allocation towards acquisitions.
I think we should gradually see a slight increase in R&D expenses to support organic growth. In my mind, that would be the wise thing to do if you don't squeeze the company too much. That's the piece there.
This is a snippet of the transcript, sign up to read more.
Related Content
Becton Dickinson: M&A History, Culture & Management
Former Senior Executive at Becton Dickinson
Bonesupport: US Sales Process & Growth Opportunity
Former Sales Executive at Bonesupport
Bonesupport: CERAMENT, Bone Infections & Use Cases
Former Sales Manager at Bonesupport
Bonesupport: History, Competition & Market Size
Former Senior Sales Executive at Bonesupport
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.